← Open Payments lookup

KAIWEN JIANG: Open Payments

NPI 1366035750 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,956 in 96 payments from 16 companies in 2025. Trend: 2023 $1,215 · 2024 $1,562 · 2025 $1,956

Food & beverage: $1,956
CompanyPaymentsAmount
ABBVIE INC.26$564
Otsuka America Pharmaceutical, Inc.7$342
E.R. Squibb & Sons, L.L.C.16$223
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$207
Vanda Pharmaceuticals Inc.10$169
Alkermes, Inc.5$106
Axsome Therapeutics, Inc.4$96
Luye Pharma (USA) Ltd.2$42
Supernus Pharmaceuticals, Inc.2$36
Neurocrine BioSciences, Inc.2$36

Products named: VRAYLAR, ABILIFY MAINTENA, COBENFY, CAPLYTA, FANAPT, Auvelity, ABILIFY ASIMTUFII, ARISTADA.

Industry payments across NV — which companies pay providers there.